Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer

Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer

Eftimia Boutsikou,1 Theodoros Kontakiotis,1 Paul Zarogoulidis,1 Kaid Darwiche,2 Ellada Eleptheriadou,1 Konstantinos Porpodis,1 Grammati Galaktidou,3 Leonidas Sakkas,4 Wolfgang Hohenforst-Schmidt,5 Kosmas Tsakiridis,6 Theodoros Karaiskos,7 Konstantinos Zarogoulidis11Pulmonary Department-Oncology Unit...

Full description

Bibliographic Details
Main Authors: Boutsikou E, Kontakiotis T, Zarogoulidis P, Darwiche K, Eleptheriadou E, Porpodis K, Galaktidou G, Sakkas L, Hohenforst-Schmidt W, Tsakiridis K, Karaiskos T, Zarogoulidis K
Format: Article
Language:English
Published: Dove Medical Press 2013-03-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/docetaxel-carboplatin-in-combination-with-erlotinib-andor-bevacizumab--a12334

Internet

http://www.dovepress.com/docetaxel-carboplatin-in-combination-with-erlotinib-andor-bevacizumab--a12334

Similar Items